Apyx Medical (APYX) Net Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.94% |
| Dec 31, 2025 | 44.69% |
| Sep 30, 2025 | -9.77% |
| Jun 30, 2025 | 22.25% |
| Mar 31, 2025 | 37.18% |
| Dec 31, 2024 | 24.80% |
| Sep 30, 2024 | 1.94% |
| Jun 30, 2024 | -16.35% |
| Mar 31, 2024 | -19.17% |
| Dec 31, 2023 | 23.69% |
| Sep 30, 2023 | -35.15% |
| Jun 30, 2023 | 36.80% |
| Mar 31, 2023 | 46.22% |
| Dec 31, 2022 | -63.81% |
| Sep 30, 2022 | -43.82% |
| Jun 30, 2022 | -38.83% |
| Mar 31, 2022 | -9.77% |
| Dec 31, 2021 | -15.22% |
| Sep 30, 2021 | -277.20% |
| Jun 30, 2021 | -105.84% |
| Mar 31, 2021 | 0.38% |
| Dec 31, 2020 | -1.95% |
| Sep 30, 2020 | -23.24% |
| Jun 30, 2020 | -31.68% |
| Mar 31, 2020 | -22.64% |
| Dec 31, 2019 | -53.99% |
| Sep 30, 2019 | -61.70% |
| Jun 30, 2019 | 100.84% |
| Mar 31, 2019 | 72.05% |
| Dec 31, 2018 | -45.13% |
| Mar 31, 2018 | -26.72% |
| Dec 31, 2017 | 28.22% |
| Sep 30, 2017 | -12.22% |
| Jun 30, 2017 | -27.79% |
| Mar 31, 2017 | -31.11% |
| Dec 31, 2016 | 63.25% |
| Sep 30, 2016 | 15.06% |
| Jun 30, 2016 | -16.05% |
| Mar 31, 2016 | -41.87% |